Cold physical plasma-induced oxidation of cysteine yields reactive sulfur species (RSS)

Q1 Medicine
Giuliana Bruno , Thea Heusler , Jan-Wilm Lackmann , Thomas von Woedtke , Klaus-Dieter Weltmann , Kristian Wende
{"title":"Cold physical plasma-induced oxidation of cysteine yields reactive sulfur species (RSS)","authors":"Giuliana Bruno ,&nbsp;Thea Heusler ,&nbsp;Jan-Wilm Lackmann ,&nbsp;Thomas von Woedtke ,&nbsp;Klaus-Dieter Weltmann ,&nbsp;Kristian Wende","doi":"10.1016/j.cpme.2019.100083","DOIUrl":null,"url":null,"abstract":"<div><h3>Purpose</h3><p>Studying plasma liquid chemistry can reveal insights into their biomedical effects, i.e. to understand the direct and indirect processes triggered by the treatment in a model or clinical application. Due to the reactivity of the sulfur atom, thiols are potential targets for plasma- derived reactive species. Being crucial for protein function and redox signaling pathways, their controllable modification would allow expanding the application range. Additionally, models to control and standardize CAP sources are desired tools for plasma source design.</p></div><div><h3>Methods</h3><p>Cysteine, a ubiquitous amino acid, was used as a tracer compound to scavenge the reactive species produced by an argon plasma jet (kINPen). The resulting product pattern was identified via high-resolution mass spectrometry. The Ellman´s assay was used to screen CAP derived thiol consumption, and long-lived species deposition (hydrogen peroxide, nitrite, nitrate) was monitored in relation to the presence of cysteine.</p></div><div><h3>Results</h3><p>The intensity of cysteine oxidation increased with treatment time and availability of oxygen in the feed gas. A range of products from cysteine was identified, in part indicative for certain treatment conditions. Several non-stable products occur transiently during the plasma treatment. Bioactive reactive sulfur species (RSS) have been found for mild treatment conditions, such as cysteine sulfoxides and cysteine-<em>S</em>-sulfonate. Considering the number of cysteine molecules in the boundary layer and the achieved oxidation state, short-lived species dominate in cysteine conversion. In addition, a boundary layer depletion of the tracer was observed.</p></div><div><h3>Conclusion</h3><p>Translating these data into the in-vivo application, strong direct oxidation of protein thiol groups with subsequent changes in protein biochemistry must be considered. Plasma-derived RSS may in part contribute to the observed biomedical effects of CAP. Care must be taken to control the discharge parameter tightly as chemical dynamics at or in the liquid are subject to change easily.</p></div>","PeriodicalId":46325,"journal":{"name":"Clinical Plasma Medicine","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2019-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.cpme.2019.100083","citationCount":"28","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Plasma Medicine","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2212816618300301","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 28

Abstract

Purpose

Studying plasma liquid chemistry can reveal insights into their biomedical effects, i.e. to understand the direct and indirect processes triggered by the treatment in a model or clinical application. Due to the reactivity of the sulfur atom, thiols are potential targets for plasma- derived reactive species. Being crucial for protein function and redox signaling pathways, their controllable modification would allow expanding the application range. Additionally, models to control and standardize CAP sources are desired tools for plasma source design.

Methods

Cysteine, a ubiquitous amino acid, was used as a tracer compound to scavenge the reactive species produced by an argon plasma jet (kINPen). The resulting product pattern was identified via high-resolution mass spectrometry. The Ellman´s assay was used to screen CAP derived thiol consumption, and long-lived species deposition (hydrogen peroxide, nitrite, nitrate) was monitored in relation to the presence of cysteine.

Results

The intensity of cysteine oxidation increased with treatment time and availability of oxygen in the feed gas. A range of products from cysteine was identified, in part indicative for certain treatment conditions. Several non-stable products occur transiently during the plasma treatment. Bioactive reactive sulfur species (RSS) have been found for mild treatment conditions, such as cysteine sulfoxides and cysteine-S-sulfonate. Considering the number of cysteine molecules in the boundary layer and the achieved oxidation state, short-lived species dominate in cysteine conversion. In addition, a boundary layer depletion of the tracer was observed.

Conclusion

Translating these data into the in-vivo application, strong direct oxidation of protein thiol groups with subsequent changes in protein biochemistry must be considered. Plasma-derived RSS may in part contribute to the observed biomedical effects of CAP. Care must be taken to control the discharge parameter tightly as chemical dynamics at or in the liquid are subject to change easily.

冷物理等离子体诱导半胱氨酸氧化产生活性硫(RSS)
目的:研究等离子体液体化学可以揭示其生物医学效应,即了解模型或临床应用中治疗引发的直接和间接过程。由于硫原子的反应性,硫醇是等离子体衍生反应物质的潜在目标。作为蛋白质功能和氧化还原信号通路的关键,它们的可控修饰将扩大应用范围。此外,控制和标准化CAP源的模型是等离子体源设计所需的工具。方法采用半胱氨酸作为示踪剂,清除氩等离子体射流(kINPen)产生的活性物质。通过高分辨率质谱分析确定了所得产品的模式。Ellman’s法用于筛选CAP衍生的硫醇消耗,并监测与半胱氨酸存在相关的长寿命物种沉积(过氧化氢,亚硝酸盐,硝酸盐)。结果半胱氨酸氧化强度随处理时间和原料气中氧含量的增加而增加。从半胱氨酸中鉴定出一系列产品,部分指示某些治疗条件。在等离子体处理过程中,会有几种不稳定的产物出现。半胱氨酸亚砜和半胱氨酸-s -磺酸盐等生物活性活性硫(RSS)在温和的处理条件下已被发现。考虑到边界层中半胱氨酸分子的数量和达到的氧化状态,短寿命物种在半胱氨酸转化中占主导地位。此外,还观察到示踪剂的边界层耗竭。结论将这些数据转化为体内应用,必须考虑蛋白质巯基的强烈直接氧化和随后的蛋白质生化变化。等离子体衍生的RSS可能在一定程度上促成了CAP所观察到的生物医学效应。必须注意严格控制放电参数,因为液体或液体中的化学动力学很容易发生变化。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Clinical Plasma Medicine
Clinical Plasma Medicine MEDICINE, RESEARCH & EXPERIMENTAL-
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信